Aswin Thacharodi & Iain L. Lamont. (2022). Aminoglycoside-Modifying Enzymes Are Sufficient to Make <i>Pseudomonas aeruginosa</i> Clinically Resistant to Key Antibiotics. MDPI AG.
Chicago Style (17th ed.) CitationAswin Thacharodi and Iain L. Lamont. Aminoglycoside-Modifying Enzymes Are Sufficient to Make <i>Pseudomonas Aeruginosa</i> Clinically Resistant to Key Antibiotics. MDPI AG, 2022.
MLA (9th ed.) CitationAswin Thacharodi and Iain L. Lamont. Aminoglycoside-Modifying Enzymes Are Sufficient to Make <i>Pseudomonas Aeruginosa</i> Clinically Resistant to Key Antibiotics. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.